Kevin Lomangino is the managing editor of HealthNewsReview.org. He tweets as @KLomangino.
A bureaucratic snafu in England has generated international headlines bemoaning the deaths of hundreds of women.
Some coverage, such as this CNN story picked up by KSAT in San Antonio, brought visions of a mass casualty event on the scale of a terrorist attack or airline crash:
Dozens of other news outlets chimed in with similarly explosive framing:
The coverage focuses on a computer error at the National Health Service that caused some 450,000 older women (ages 68 to 71) not to receive scheduled invitations for a mammogram.
As a result, the stories claim, between 135 and 270 women may have died from breast cancer that could have been detected and treated earlier with lifesaving results. UK Health Secretary Jeremy Hunt is referenced as the source of these figures.
What’s the problem with these stories?
For starters, neither breast cancer screening nor any other form of cancer screening has been shown to reduce overall mortality, which is the best measure of whether lives are actually being saved or not.
For this reason, no one can say with any certainty whether mammograms would have saved these women — or whether the lack of a mammogram killed them.
Breast cancer screening has been shown to modestly reduce deaths from breast cancer. (About 1,000 50-year-old women need to be screened for 10 years to prevent one death from breast cancer.) However, this small benefit evaporates when other causes of death, such as cardiovascular disease, are factored in.
Why is this important? It’s possible that for some women, radiation and other toxic therapies that are used to treat screen-detected cancers may ultimately increase the likelihood of dying earlier from some other cause–canceling out any reduction in deaths from breast cancer.
That’s why it’s treacherous to consider lives “saved” by a reduction in deaths from a specific disease. The treatment of that disease may ultimately increase deaths through some other unrelated mechanism.
Another problem with this coverage is that it doesn’t adequately acknowledge the risk of overdiagnosis — the detection of cancers that never would have caused health problems or death. Some cancers are slow-growing and might never pose a risk to the patient, while others are very aggressive and may spread despite the earliest possible detection and treatment.
A recent Danish study estimated that about one-third of all mammography-detected breast cancers represent overdiagnosis. This means that women treated for these cancers had no chance to benefit, but experience all the harms of cancer treatment that may include surgery, chemotherapy, and radiation.
Christine Norton, president and co-founder of the Minnesota Breast Cancer Coalition and a breast cancer survivor, called the headline and first paragraph of KSAT’s CNN story “the epitome of disease mongering.”
“Combined they engender fear not only in older women in the UK who were among those not invited to be screened but also in any woman of any age who has thought about the possibility of breast cancer,” she said.
UK Health Minister Jeremy Hunt addresses Parliament.
Norton said it was inaccurate and irresponsible to blame up to 270 deaths on a failure to invite women for breast cancer screening. “The more accurate and responsible statement is the quote in paragraph 5 [of the CNN story] by the UK Health Secretary, Jeremy Hunt, who noted that ‘At this stage it is unclear whether any delay in diagnosis will have resulted in any avoidable harm or death.’ Based on multiple studies, it’s more accurate to state that breast cancer screening results in false positives, over-diagnosis, and over-treatment.”
The point is not that mammograms are useless and should be avoided — it’s that the benefits are probably smaller than most women have been led to believe, and that those benefits are accompanied by significant harms that many women have never been warned about. Women are making decisions about mammograms based on incomplete, imbalanced information. News coverage of mammograms doesn’t help when it reinforces misconceptions about the effectiveness of screening and doesn’t address the harms.
According to the CNN coverage, “Health officials will contact the next of kin of women who are thought to have missed a scan and subsequently died of breast cancer, Hunt said. They will apologize and offer a process to establish whether the error led to an earlier death, and if compensation might be payable.”
This statement raises some interesting questions:
None of the superficial stories that I read about this situation asked these legitimate questions.
They missed an opportunity to bring balance to what is typically a one-sided message about breast cancer screening.
Editor’s note: A previous version of this story referred to “the UK’s breast cancer screening computer glitch” in the headline. References to a “UK” glitch have been changed to “England,” since the glitch only affected women in England and not Scotland, Wales, or Northern Ireland.
Comments (3)
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Kate Gilderdale
May 4, 2018 at 8:59 amThank you so much for this. Over the years, I have spent a lot of time researching the pros and cons of screening and, as a result, I have never had a mammogram. Of course this is a deeply personal choice and one I would not try and push on others who have come to a different conclusion, but when I read such misleading headlines and reports, it really upsets me.
Caroline Helwick
May 7, 2018 at 7:01 amColonoscopy, which is the the most effective form of colorectal cancer screening, HAS been shown in large studies to reduce deaths from colorectal cancer. This is from a landmark Canadian study by Baxter et al: Complete colonoscopy was strongly associated with fewer deaths from left-sided CRC (OR, 0.33 but not from right-sided CRC (Baxter N. Ann Int Med. 2008;150:1). More recently in a study of almost 5,000 veterans, Kahl et al found: Colonoscopy was associated with reduced mortality for left-sided cancer (OR, 0.28) and right-sided cancer (OR, 0.54]). The results were similar for patients who had undergone screening colonoscopy (overall OR, 0.33)
Kevin Lomangino
May 7, 2018 at 7:40 amHi Caroline,
Thanks for reading and commenting. However, your statement is inaccurate. The only colorectal cancer screening tests that have been proven efficacious in reducing colorectal cancer incidence and mortality, i.e., evaluated in randomized controlled trials, are fecal blood tests and flexible sigmoidoscopy. Your claims are based on observational studies, which cannot prove cause and effect and cannot be used as the basis for claiming a reduction in cancer deaths. Importantly, I also pointed out that no cancer screening test (including colonoscopy) has been shown in a randomized controlled trial to reduce TOTAL mortality, which is the best measure of whether lives are actually being “saved” or not.
Kevin Lomangino
Managing Editor
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like